Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

Share Price is delayed by 15 minutes
Get Live Data
401.50    -0.50 (-0.12%)
Bid:
400.50
Ask:
403.00
Spread: 2.50 (0.624%)
Market Cap: £1.63b
PIN Live PriceLast checked at - London Stock Exchange

Intraday Pantheon International Share Chart

Monthly Performance Update

27 Jan 2025 07:00

RNS Number : 6650U
Pantheon International PLC
27 January 2025
Β 

27 January 2025

Β 

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, Canada, Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia), Japan, the Republic of South Africa or any other jurisdiction where its release, publication or distribution is or may be unlawful.

Pantheon International Plc

("PIP" or the "Company")

Β 

Performance Update at 31 December 2024

Β 

Performance Update at 31 December 2024

Β 

504.2p NAV per share

+0.5% NAV per share growth for the month

Β£2.3bn Net asset value

+83% Total NAV per share return (5Y)*

Β£1.5bn Market capitalisation

+25% Total shareholder return (5Y)*

Β£46.9m Net portfolio cash flow**

4.1x Financing cover***

Β 

Β 

Month to 31 December 2024

Β 

PIP announced an unaudited net asset value ("NAV") per share of 504.2p as at 31 December 2024, an increase of +2.6p (+0.5%) from the NAV per share as at 30 November 2024.

In the month to 31 December 2024, valuation losses** were -2.1p (-0.4%), investment income** added +0.7p (+0.1%), foreign exchange movements** were +4.9p (+1.0%), share buybacks added +0.0p (+0.0%) and expenses and taxes**** were -0.9p (-0.2%).

PIP's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which PIP has holdings. In the case of PIP's valuation as at 31 December 2024, 7% of reported valuations are dated 31 December 2024 or later, 85% are dated 30 September 2024 and 8% are dated 30 June 2024. Of the 7% of valuations dated 31 December 2024 or later, 5.0% reflect the mark-to-market fair value adjustment for PIP's listed company holdings.

At 31 December 2024, PIP's private equity assets stood at Β£2,529m, whilst net available cash balances^ were Β£61m. The Asset Linked Note^^ ("ALN") outstanding as at 31 December 2024 amounted to Β£26m. Undrawn commitments to investments stood at Β£739m as at 31 December 2024, calculated using exchange rates at that date. PIP maintains a Β£400m^^^ multi-tranche, multi-currency revolving credit facility. As at 31 December 2024, Β£117m was drawn down under the credit facility and $150m (Β£120m GBP equivalent as at month end) of private placement notes were outstanding, resulting in a net debt to NAV ratio of 7.6%.^^^^

Β 

Net Portfolio Cash Flow

Β 

PIP received distributions of Β£72.3m relative to Β£25.4m of calls from existing commitments to private equity funds. Therefore, PIP's portfolio generated net cash of Β£46.9m during the month.

Β 

New Investments

Β 

Although the Company made no significant new commitments during the month, PIP's pipeline points to an active period for new commitments in the months ahead.

Β 

Share Buybacks

Β 

PIP invested Β£0.3m in share buybacks during the month, acquiring 85,000 shares at a weighted average price of 339.9p per share. This price represented an average discount of 30.7% to the prevailing NAV per share at the time of the transactions. As at 31 December 2024, PIP has allocated a total of Β£10.0 million for share buybacks in the current financial year, of which PIP has invested a total of Β£9.5 million.

Β 

* Based on the change in the NAV per share and ordinary share price over the period.

** Figures are stated net of movements associated with the ALN share of the reference portfolio. Valuation movement includes the mark-to-market fair value adjustment of listed company holdings.

***Ratio of net available cash, portfolio value and undrawn credit facility to outstanding commitments. Outstanding commitments relating to funds outside their investment period (>13 years old) were excluded from the calculation as there is a low likelihood of these being drawn. This amounted to Β£40.3m as at 31 December 2024.

**** Operating expenses, financing costs and withholding taxes on investment distributions.

^Net available cash calculated as cash and net current assets / (liabilities) less undistributed net cashflows associated with the ALN.

^^Unlisted 10-year note issued on 31 October 2017 whose cost and repayments are linked to a reference portfolio consisting of the Company's older vintage funds.

^^^ PIP maintains a Β£400m multi-currency credit facility. The overall credit facility comprises facilities of US$393.0m and €120.0m and had a sterling equivalent value of Β£412.9m as at 31 December 2024. As at 31 December 2024, PIP had drawn down Β£117.3m of the credit facility.

^^^^Net debt calculated as borrowings (excluding the outstanding balance of the Asset Linked Note) less net available cash. The ALN is not considered in the calculation of gross borrowings or the loan-to-value ratio, as defined in PIP's credit facility and note agreements. If the ALN is included, net debt to NAV was 8.7% as at 31 December 2024.

Β 

Annualised Performance as at 31 December 2024^^^^^

Β 

1 Year

(% p.a.)

3 Years

(% p.a.)

5 Years

(% p.a.)

10 Years

(% p.a.)

Since Inception

(% p.a.)

Β 

NAV per share

5.6%

6.7%

12.9%

12.8%

11.8%

Ordinary share price

3.5%

-1.4%

4.6%

9.8%

10.7%

FTSE All-Share, TR

9.5%

5.8%

4.8%

6.2%

7.5%

MSCI World TR, (Β£)

21.3%

9.7%

13.0%

13.0%

8.8%

^^^^^PIP was launched on 18 September 1987. The performance figures for PIP assume reinvestment of dividends and capital.

Discrete Performance as at 31 December 2024

Β 

31/12/2023- 31/12/2024

31/12/2022- 31/12/2023

31/12/2021- 31/12/2022

31/12/2020- 31/12/2021

31/12/2019- 31/12/2020

NAV per share

5.6%

2.3%

12.4%

34.3%

12.4%

Ordinary share price

3.5%

19.6%

-22.6%

34.1%

-2.7%

FTSE All-Share, TR

9.5%

7.9%

0.3%

18.3%

-9.8%

MSCI World TR, (Β£)

21.3%

17.4%

-7.4%

23.5%

12.9%

Β 

Largest Holdings

Β 

Largest companies by value as at 30 November 2024

Β 

Company

Country

Sector

% of portfolio

Kaseya

Switzerland

Information Technology

1.3%

Visma

Norway

Information Technology

1.2%

Action

Netherlands

Consumer

1.2%

Smile Doctors

USA

Healthcare

0.9%

John Staurulakis

USA

Industrials

0.9%

Β 

Largest managers by value as at 30 November 2024

Β 

Manager

Region

% of portfolio

Insight Partners

USA

6.9%

Index Ventures

Global

4.0%

HgCapital

Europe

3.8%

Providence Equity Partners

USA

3.2%

Parthenon Capital

USA

2.6%

Β 

Monthly Report

Β 

The December 2024 newsletter can be accessed on PIP's website at www.piplc.com in the Investor Relations section under the heading "Newsletters".

Β 

This announcement contains inside information.

Β 

Ends

Β 

LEI: 2138001B3CE5S5PEE928

Β 

For more information please visit PIP's website at www.piplc.com or contact:

Β 

Pantheon

Helen Steers MBE / Charlotte Morris / Vicki Bradley

Tel: +44 20 3356 1800

Follow us on LinkedIn:Β https://www.linkedin.com/company/pantheon-international-plc

NOTES

Β 

PIP

PIPΒ is aΒ listed FTSE 250 private equity investment trust, overseenΒ by anΒ independent Board of Directors and managed by Pantheon, one of the leading private equity investment managers globally. PIP offers investorsΒ a liquid, differentiated entry point to the excellent growth potential of global private equity, with access to the primary, secondary and co-investment opportunities of some of the best managers in the world. The Company has a track record of NAV outperformance over the long term and manages risk strategically through diversification and rigorous selection based on Pantheon's extensive experience and international platform, and robust investment due diligence and decision-making processes.

Β 

Pantheon

PIP is managed and advised by Pantheon, a specialist global private markets investor. Pantheon has been at the forefront of private markets investing for more than 40 years, earning a reputation for providing innovative solutions covering the full lifecycle of investments, across private equity, real assets and private credit. The firm has partnered with more than 680 clients, with approximately $68bn in discretionary assets under management (as at 30 June 2024).

Β 

Important Information

A copy of this announcement will be available on the Company's website at www.piplc.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

John Singer CBE

Chair, Pantheon International Plc

Broadwalk House, Southernhay West, Exeter, Devon EX1 1TS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDFLFEVLFISFIE
Date   Source Headline
20th Mar 20204:38 pmRNSPrice Monitoring Extension
5th Mar 20201:00 pmRNSChange in Audit Committee Responsibilities
2nd Mar 20203:10 pmEQSHardman & Co Research: Pantheon International Plc (PIN): 2020 interim results: consistency in delivery
27th Feb 20207:00 amRNSHalf-year Report
25th Feb 20207:00 amRNSMonthly Performance Update
24th Jan 20207:00 amRNSMonthly Performance Update
17th Jan 20202:47 pmRNSDirector Declaration
9th Jan 202012:47 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSMonthly Performance Update
10th Dec 201911:57 amRNSDirector/PDMR Shareholding
5th Dec 201912:44 pmRNSDirector/PDMR Shareholding
26th Nov 20192:45 pmEQSHardman & Co Research: Pantheon International Plc (PIN): History of value added to portfolio by holding Pantheon
26th Nov 20197:00 amRNSMonthly Performance Update
6th Nov 20194:08 pmRNSDirector/PDMR Shareholding
30th Oct 20195:14 pmRNSResult of AGM
25th Oct 20197:00 amRNSMonthly Performance Update
24th Oct 20195:11 pmRNSDirector Declaration
26th Sep 20197:00 amRNSMonthly Performance Update
9th Sep 20197:00 amRNSAppointment of Non-Executive Director
6th Sep 20197:30 amEQSHardman & Co Research: Pantheon International Plc (PIN) - (Initiation of coverage): 11.9% average annual NAV growth since 1987
22nd Aug 20197:00 amRNSMonthly Performance Update
8th Aug 20192:41 pmRNSDirector/PDMR Shareholding
7th Aug 20197:05 amRNSAnnual Financial Report
7th Aug 20197:00 amRNSAppointment of Non-Executive Director
26th Jul 20197:00 amRNSMonthly Performance Update
11th Jul 20197:00 amRNSMonthly Performance Update
22nd May 20197:00 amRNSMonthly Performance Update
26th Apr 20197:00 amRNSMonthly Performance Update
26th Mar 20197:00 amRNSMonthly Performance Update
27th Feb 20197:00 amRNSHalf-year Report
26th Feb 20197:00 amRNSMonthly Performance Update
1st Feb 201911:37 amRNSTotal Voting Rights
25th Jan 20197:00 amRNSMonthly Performance Update
10th Jan 20196:05 pmRNSTotal Voting Rights
10th Jan 20196:03 pmRNSTransaction in Own Shares
10th Jan 201911:54 amRNSDirector/PDMR Shareholding
10th Jan 20197:00 amRNSMonthly Performance Update
23rd Nov 20187:00 amRNSMonthly Performance Update
31st Oct 201812:02 pmRNSResult of AGM
23rd Oct 20187:00 amRNSMonthly Performance Update
26th Sep 20187:00 amRNSMonthly Performance Update
22nd Aug 20187:00 amRNSMonthly Performance Update
8th Aug 20187:00 amRNSAnnual Financial Report
31st Jul 20187:00 amRNSMonthly Performance Update
12th Jul 20187:00 amRNSMonthly Performance Update
11th Jul 201812:43 pmRNSDirector Declaration
5th Jun 20185:01 pmRNSDirector/PDMR Shareholding
4th Jun 20189:08 amRNSRenewal of Credit Facility
1st Jun 20182:44 pmRNSDirector/PDMR Shareholding
23rd May 20187:00 amRNSMonthly Performance Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.